Key Takeaways: Testosterone side effects in women are dose-dependent and mostly mild at physiological replacement levels. The most common are acne, mild hair changes, and oily skin. Voice deepening and clitoral enlargement are rare but potentially irreversible -- catch them early. Cardiovascular and breast cancer data at physiological doses is reassuring but long-term studies beyond 2 years are limited.
The Dose-Response Relationship
Nearly every side effect of testosterone in women is dose-dependent. At physiological replacement doses (5-10 mg/day topical, achieving total testosterone of 50-70 ng/dL), side effects are infrequent and mild. As doses exceed physiological levels, side effects increase in frequency and severity.
This is why the 2019 Global Consensus Position Statement emphasized using only formulations that achieve physiological testosterone levels in women. Supraphysiological dosing -- the kind used by some anti-aging clinics or in athletic contexts -- carries substantially higher risk.
Side Effects by Frequency
Common (5-20% of women)
Acne
The most frequently reported side effect. Testosterone stimulates sebaceous glands, increasing oil production. Acne tends to be:
- Concentrated along the jawline and chin (hormonal pattern)
- Mild to moderate in severity
- Most common in the first 2-3 months
- Often self-resolving as the body adjusts
Management:
- Topical retinoids (adapalene, tretinoin) as first-line treatment
- Benzoyl peroxide wash for mild cases
- Low-dose spironolactone (25-50 mg) can counteract testosterone's effect on sebaceous glands without negating systemic benefits
- Dose reduction if acne is severe or persistent
- Switching application site may help if acne clusters near the application area
Increased Facial/Body Hair
Slight darkening or coarsening of vellus (fine) hair, particularly on the upper lip, chin, and forearms. At physiological doses, this is subtle -- not the coarse, dark hair growth seen with significant androgen excess.
Management:
- Standard hair removal methods (threading, waxing, laser)
- Eflornithine cream (Vaniqa) slows facial hair growth
- Dose reduction if hair growth is bothersome
- Generally reversible with dose adjustment
Oily Skin and Scalp
Increased sebum production affects both facial skin and scalp. Hair may feel greasier and require more frequent washing.
Management:
- Oil-control skincare products
- More frequent cleansing
- Usually normalizes within 2-3 months as the body adjusts
- Dose reduction if problematic
Uncommon (1-5% of women)
Scalp Hair Thinning
Androgenetic alopecia (female pattern hair loss) can occur if testosterone levels are too high or if the individual is genetically susceptible. The thinning affects the crown and part line, sparing the frontal hairline (unlike male pattern baldness).
Management:
- Dose reduction is the first step
- Topical minoxidil (2% or 5%) can counteract thinning
- Oral finasteride or dutasteride block conversion to DHT but carry pregnancy risks
- Nutritional support: iron, biotin, zinc, vitamin D
- Typically reversible if caught early
Mood Changes
Some women experience increased irritability, impatience, or aggressive feelings. This is more common at higher doses and may indicate testosterone levels are above the optimal range.
Management:
- Check blood levels -- irritability often corresponds with supraphysiological testosterone
- Dose reduction usually resolves mood changes within 2-4 weeks
- If mood changes persist at therapeutic levels, explore other causes
Fluid Retention
Mild water retention can occur, particularly in the first few weeks. This is usually transient and not clinically significant.
Management:
- Typically self-resolving
- Adequate hydration and moderate sodium intake
- Dose reduction if significant
Rare (Less than 1%)
Voice Deepening
Changes to the vocal cords that lower voice pitch. This is the most concerning side effect because it may be irreversible.
Presentation:
- Hoarseness or vocal fatigue as the earliest sign
- Gradual lowering of pitch over weeks to months
- More common with injections (due to higher peak levels) and supraphysiological dosing
Management:
- Stop testosterone immediately if any voice change is noticed
- Consult an ENT/voice specialist for evaluation
- Some degree of reversal is possible if caught very early
- May be permanent if treatment continues after voice changes begin
Risk context: At standard physiological doses (5-10 mg/day topical), voice deepening is exceedingly rare. It becomes a meaningful risk at doses that produce testosterone levels above 100 ng/dL.
Clitoral Enlargement (Clitoromegaly)
Increased clitoral size due to androgen stimulation of genital tissue. Like voice changes, this may be irreversible.
Presentation:
- Gradual increase in clitoral size
- Increased sensitivity (which some women view as positive)
- More common with supraphysiological dosing
Management:
- Reduce dose or stop testosterone
- Mild enlargement may partially reverse; significant enlargement is often permanent
- At physiological doses, clinically significant enlargement is rare
Liver Effects
Primarily a concern with oral testosterone preparations (not commonly used in women). Transdermal delivery bypasses first-pass liver metabolism and has minimal hepatic impact.
- No significant liver function changes demonstrated with topical testosterone in clinical trials
- Oral preparations (which are uncommon for women) can affect liver enzymes
- Routine liver function testing is not required for topical testosterone but is part of standard annual labs
